Viewing Study NCT02260661


Ignite Creation Date: 2025-12-24 @ 12:58 PM
Ignite Modification Date: 2026-01-07 @ 4:05 PM
Study NCT ID: NCT02260661
Status: COMPLETED
Last Update Posted: 2016-10-10
First Post: 2014-10-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I, Dose Study to Look at the Safety and Pharmacokinetics of AZD8835 in Patients With Advanced Solid Tumours
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module